Sfoglia per AUTORE
BOTTOS A
Collezione AO Ordine Mauriziano

  

Items : 2

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. in Molecular cancer / Mol Cancer. 2009 Dec 10;8:118. doi: 10.1186/1476-4598-8-118.

2009
AO Ordine Mauriziano
AOU Città della Salute di Torino

Aglietta M; Picci P; Fagioli F; Bussolino F; Ferrari S; Torchio B; Alberghini M; Camussi G; Migliardi G; Gammaitoni L; Bottos A; Bruno S; Tapparo M; Motta M; Cavalloni G; Pignochino Y; Grignani G;

Sorafenib blocks tumor growth, angiogenesis, and metastatic potential in preclinical models of osteosarcoma through the inhibition of ERK1/2, MCL-1, and ezrin pathways in Molecular Cancer Therapeutics

2009
AO Ordine Mauriziano

Pignochino Y; Grignani G; Cavalloni G; Tapparo M; Motta M; Bruno S; Bottos A; Gammaitoni L; Camussi G; Migliardi G; Alberghini M; Torchio B; Ferrari S; Picci P; Fagioli F; Aglietta M;